Edap Tms (NASDAQ:EDAP) Rating Increased to Hold at ValuEngine

Edap Tms (NASDAQ:EDAP) was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Friday, ValuEngine reports.

A number of other research analysts also recently issued reports on EDAP. Zacks Investment Research downgraded Edap Tms from a “buy” rating to a “hold” rating in a research note on Wednesday, January 15th. HC Wainwright restated a “buy” rating and set a $6.50 target price on shares of Edap Tms in a research note on Friday, November 15th.

Shares of NASDAQ:EDAP traded up $0.13 during midday trading on Friday, hitting $4.19. The company had a trading volume of 147,372 shares, compared to its average volume of 105,405. The company has a market cap of $121.51 million, a price-to-earnings ratio of 32.23 and a beta of 1.62. Edap Tms has a 12-month low of $2.54 and a 12-month high of $5.42. The company has a fifty day moving average of $4.37 and a two-hundred day moving average of $4.06.

Edap Tms (NASDAQ:EDAP) last announced its earnings results on Wednesday, November 13th. The medical equipment provider reported $0.03 EPS for the quarter, missing the Zacks’ consensus estimate of $0.04 by ($0.01). Edap Tms had a return on equity of 40.29% and a net margin of 7.61%. The company had revenue of $11.35 million during the quarter, compared to the consensus estimate of $13.15 million. On average, equities analysts expect that Edap Tms will post 0.14 earnings per share for the current year.

A number of institutional investors have recently modified their holdings of EDAP. Morgan Stanley raised its position in shares of Edap Tms by 222.7% during the second quarter. Morgan Stanley now owns 267,408 shares of the medical equipment provider’s stock valued at $722,000 after buying an additional 184,539 shares during the last quarter. Susquehanna International Group LLP grew its stake in Edap Tms by 762.9% during the second quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment provider’s stock valued at $556,000 after acquiring an additional 181,401 shares in the last quarter. Accredited Investors Inc. increased its holdings in Edap Tms by 53.9% in the 4th quarter. Accredited Investors Inc. now owns 147,816 shares of the medical equipment provider’s stock valued at $655,000 after acquiring an additional 51,800 shares during the last quarter. JPMorgan Chase & Co. bought a new position in shares of Edap Tms during the 2nd quarter valued at about $282,000. Finally, Commonwealth Equity Services LLC grew its position in shares of Edap Tms by 25.0% during the third quarter. Commonwealth Equity Services LLC now owns 32,540 shares of the medical equipment provider’s stock valued at $146,000 after purchasing an additional 6,500 shares in the last quarter. 12.04% of the stock is owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).

Further Reading: What are no-load funds?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit